Bolt Biotherapeutics chief medical officer Edith Perez joins fellow cancer researchers in Stand Up to Cancer's new PSA.
April 13, 2023 02:42 PM EDTUpdated April 17, 07:47 PM
Pharma
Marketing

Biotech and can­cer cen­ter re­searchers star in Stand Up To Can­cer’s lat­est com­mer­cial

Beth Snyder Bulik

Senior Editor

Stand Up To Can­cer’s newest pub­lic ser­vice an­nounce­ment puts the spot­light on can­cer re­searchers, in­clud­ing one from Bolt Bio­ther­a­peu­tics.

Bolt’s chief med­ical of­fi­cer Edith Perez …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times